Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 100.00% is 142% above its 5-year average of -240.24%, near the high end of its 5-year range (-98295.24%–100.00%).
As of the fiscal period ended Tuesday, June 30, 2026. 316.02% above its 12-month average of -46.29%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 100.00%.
GROSS MARGIN
100.00%
GROSS MARGIN AVG TTM
-46.29%
GROSS MARGIN AVG 3Y
-143.70%
GROSS MARGIN AVG 5Y
-240.24%
GROSS MARGIN AVG 10Y
-332.12%
GROSS MARGIN AVG 15Y
N/A
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+316.02%
CURRENT VS 3Y AVG
+169.59%
CURRENT VS 5Y AVG
+141.63%
CURRENT VS 10Y AVG
+130.11%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
47.19%
median of 504 covered companies
CURRENT VS SECTOR MEDIAN
+111.93%
vs the sector median at left
Editas Medicine, Inc.
Market Cap
$437.37M
Gross Margin
100.00%
TTM Avg
-46.29%
3Y Avg
-143.70%
5Y Avg
-240.24%
Market Cap
$417.82M
Gross Margin
95.50%
TTM Avg
97.75%
3Y Avg
98.88%
5Y Avg
1.50%
Market Cap
$412.94M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
12.37%
Market Cap
$445.71M
Gross Margin
0.00%
TTM Avg
-62.19%
3Y Avg
-231.05%
5Y Avg
-120.70%
Market Cap
$415.24M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$406.47M
Gross Margin
77.34%
TTM Avg
76.74%
3Y Avg
77.57%
5Y Avg
77.57%
Market Cap
$452.63M
Gross Margin
99.82%
TTM Avg
1.85%
3Y Avg
-144.74%
5Y Avg
-84.51%
Market Cap
$458.01M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Editas Medicine, Inc. (EDIT) | $437.37M | 100.00% | -46.29% | -143.70% | -240.24% |
| Arcturus Therapeutics Holdings Inc. (ARCT)vs › | $417.82M | 95.50% | 97.75% | 98.88% | 1.50% |
| Carlsmed, Inc. (CARL)vs › | $419.46M | 76.63% | 74.56% | 73.66% | 73.66% |
| Atea Pharmaceuticals, Inc. (AVIR)vs › | $412.94M | 0.00% | 0.00% | 0.00% | 12.37% |
| Capricor Therapeutics, Inc. (CAPR)vs › | $445.71M | 0.00% | -62.19% | -231.05% | -120.70% |
| Eikon Therapeutics, Inc. Common Stock (EIKN)vs › | $415.24M | 0.00% | 0.00% | 0.00% | 0.00% |
| Shoulder Innovations, Inc. (SI)vs › | $406.47M | 77.34% | 76.74% | 77.57% | 77.57% |
| Assembly Biosciences, Inc. (ASMB)vs › | $452.63M | 99.82% | 1.85% | -144.74% | -84.51% |
| DiaMedica Therapeutics Inc. (DMAC)vs › | $458.01M | 0.00% | 0.00% | 0.00% | 0.00% |
| Kamada Ltd. (KMDA)vs › | $465.02M | 40.82% | 42.91% | 40.22% | 37.63% |
Gross Margin
100.0%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 100.00% |
| 2026-03-31 | 82.94% |
| 2025-12-31 | 100.00% |
| 2025-09-30 | -162.16% |
| 2025-06-30 | -352.24% |
| 2025-03-31 | -470.91% |
| 2024-12-31 | -58.84% |
| 2024-09-30 | -2521.31% |
| 2024-06-30 | -176.80% |
| 2024-03-31 | -24.14% |
| 2023-12-31 | 97.56% |
| 2023-09-30 | 71.63% |
| 2023-06-30 | -931.49% |
| 2023-03-31 | -283.76% |
| 2022-12-31 | -695.56% |
| 2022-09-30 | -98295.24% |
| 2022-06-30 | -586.25% |
| 2022-03-31 | -460.86% |
| 2021-12-31 | -201.17% |
| 2021-09-30 | -372.24% |
| 2021-06-30 | -8805.80% |
| 2021-03-31 | -545.28% |
| 2020-12-31 | -438.61% |
| 2020-09-30 | 46.03% |
| 2020-06-30 | -160.55% |
| 2020-03-31 | -504.05% |
| 2019-12-31 | -183.21% |
| 2019-09-30 | -489.97% |
| 2019-06-30 | -911.37% |
| 2019-03-31 | -665.68% |
| 2018-12-31 | -434.70% |
| 2018-09-30 | -20.14% |
| 2018-06-30 | -343.81% |
| 2018-03-31 | -442.40% |
| 2017-12-31 | -620.59% |
| 2017-09-30 | -224.67% |
| 2017-06-30 | -459.19% |
| 2017-03-31 | -2689.00% |
| 2016-12-31 | -2888.31% |
| 2016-09-30 | -1025.99% |
| 2016-06-30 | -207.85% |
| 2016-03-31 | -1003.35% |
| 2015-12-31 | -635.61% |
| 2015-09-30 | -474.63% |
| 2015-06-30 | -4260.48% |
| 2015-03-31 | 0.00% |
| 2014-12-31 | 0.00% |
| 2014-09-30 | 0.00% |
| 2014-06-30 | 0.00% |
| 2014-03-31 | 0.00% |
